Susquehanna International Group, LLP Ocular Therapeutix, Inc Transaction History

Susquehanna International Group, LLP

  • $688 Billion
  • Q2 2025

A detailed history of Susquehanna International Group, LLP transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Susquehanna International Group, LLP holds 1,788,603 shares of OCUL stock, worth $22.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,788,603
Previous 439,444 307.02%
Holding current value
$22.7 Million
Previous $3.22 Million 415.31%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
BUY
$6.02 - $9.46 $8.12 Million - $12.8 Million
1,349,159 Added 307.02%
1,788,603 $16.6 Million
Q1 2025

May 14, 2025
BUY
$5.93 - $9.08 $1.94 Million - $2.98 Million
327,707 Added 293.28%
439,444 $3.22 Million
Q4 2024

Feb 14, 2025
BUY
$8.33 - $11.47 $358,931 - $494,230
43,089 Added 62.77%
111,737 $954,000
Q3 2024

Nov 14, 2024
SELL
$6.45 - $9.23 $65,919 - $94,330
-10,220 Reduced 12.96%
68,648 $597,000
Q2 2024

Aug 15, 2024
SELL
$4.2 - $8.69 $489,925 - $1.01 Million
-116,649 Reduced 59.66%
78,868 $539,000
Q1 2024

May 07, 2024
BUY
$3.85 - $10.93 $338,299 - $960,419
87,870 Added 81.63%
195,517 $1.78 Million
Q4 2023

Feb 14, 2024
BUY
$2.08 - $4.52 $89,683 - $194,888
43,117 Added 66.82%
107,647 $480,000
Q3 2023

Nov 14, 2023
SELL
$3.14 - $5.04 $976,762 - $1.57 Million
-311,071 Reduced 82.82%
64,530 $202,000
Q2 2023

Aug 11, 2023
BUY
$4.6 - $7.64 $602,701 - $1 Million
131,022 Added 53.57%
375,601 $1.94 Million
Q1 2023

May 16, 2023
BUY
$2.79 - $6.27 $313,269 - $704,014
112,283 Added 84.87%
244,579 $1.29 Million
Q4 2022

Feb 14, 2023
SELL
$2.61 - $4.41 $429,107 - $725,043
-164,409 Reduced 55.41%
132,296 $371,000
Q3 2022

Nov 14, 2022
BUY
$4.09 - $6.5 $1.08 Million - $1.71 Million
263,385 Added 790.47%
296,705 $1.23 Million
Q2 2022

Aug 15, 2022
SELL
$3.01 - $5.22 $85,505 - $148,284
-28,407 Reduced 46.02%
33,320 $134,000
Q1 2022

May 16, 2022
SELL
$4.83 - $7.35 $694,360 - $1.06 Million
-143,760 Reduced 69.96%
61,727 $306,000
Q4 2021

Feb 14, 2022
SELL
$6.16 - $12.07 $257,383 - $504,320
-41,783 Reduced 16.9%
205,487 $1.43 Million
Q2 2021

Aug 11, 2021
SELL
$13.43 - $19.16 $130,982 - $186,867
-9,753 Reduced 3.79%
247,270 $3.51 Million
Q1 2021

May 17, 2021
BUY
$15.82 - $22.11 $1.22 Million - $1.7 Million
77,063 Added 42.82%
257,023 $4.22 Million
Q4 2020

Feb 16, 2021
BUY
$7.91 - $22.95 $333,169 - $966,654
42,120 Added 30.56%
179,960 $3.73 Million
Q3 2020

Nov 16, 2020
SELL
$7.36 - $9.87 $78,001 - $104,602
-10,598 Reduced 7.14%
137,840 $1.05 Million
Q2 2020

Aug 14, 2020
BUY
$4.67 - $8.95 $633,144 - $1.21 Million
135,577 Added 1054.17%
148,438 $1.24 Million
Q1 2020

May 15, 2020
SELL
$3.95 - $7.4 $585,670 - $1.1 Million
-148,271 Reduced 92.02%
12,861 $64,000
Q4 2019

Feb 14, 2020
BUY
$2.57 - $4.73 $142,370 - $262,027
55,397 Added 52.39%
161,132 $636,000
Q3 2019

Nov 14, 2019
SELL
$3.04 - $5.32 $199,606 - $349,311
-65,660 Reduced 38.31%
105,735 $321,000
Q2 2019

Aug 16, 2019
BUY
$2.46 - $4.52 $5,313 - $9,763
2,160 Added 1.28%
171,395 $754,000
Q2 2019

Aug 14, 2019
BUY
$2.46 - $4.52 $262,287 - $481,926
106,621 Added 170.28%
169,235 $745,000
Q4 2018

Feb 14, 2019
BUY
$3.87 - $7.11 $54,895 - $100,855
14,185 Added 29.29%
62,614 $249,000
Q3 2018

Nov 14, 2018
SELL
$5.42 - $6.99 $39,257 - $50,628
-7,243 Reduced 13.01%
48,429 $333,000
Q2 2018

Aug 14, 2018
BUY
$5.99 - $8.17 $38,755 - $52,859
6,470 Added 13.15%
55,672 $375,000
Q4 2017

Feb 14, 2018
BUY
$3.73 - $6.37 $143,250 - $244,639
38,405 Added 355.7%
49,202 $219,000
Q3 2017

Nov 14, 2017
BUY
$5.28 - $6.88 $57,008 - $74,283
10,797
10,797 $67,000

Others Institutions Holding OCUL

# of Institutions
203
Shares Held
137M
Call Options Held
743K
Put Options Held
321K
View Full List

About OCULAR THERAPEUTIX, INC

OCUL Quotes by TradingView
  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $978M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email